Table 3.
Univariate analysis | Multivariate analysis | |||
---|---|---|---|---|
|
|
|||
HR (95% CI) | P value | HR (95% CI) | P value | |
Age (≥60 vs. < 60) | 0.987 (0.442–2.204) | 0.974 | ||
Gender (female vs. male) | 1.153 (0.538–2.472) | 0.714 | ||
Tumour size (≥5 vs. < 5) | 1.535 (0.737–3.198) | 0.252 | ||
AFP (≥20 vs. < 20) | 1.361 (0.679–2.729) | 0.385 | ||
TNM stage (III+IV vs. I+II) | 2.351 (1.127–4.902) | 0.023* | 2.753 (1.394–5.437) | 0.004 |
HBV infection (Yes vs. No) | 1.014 (0.468–2.199) | 0.972 | ||
Cirrhosis (Yes vs. No) | 3.643 (1.581–8.390) | 0.002** | 3.139 (1.540–6.399) | 0.002** |
Metastasis (Yes vs. No) | 2.120 (1.028–4.369) | 0.042* | 2.521 (1.320–4.814) | 0.005** |
miR-766-3p (low vs. high) | 3.699 (1.793–7.629) | < 0.001** | 3.691 (1.815–7.506) | < 0.001* |
Statistically significant (P < 0.05),
Statistically significant (P < 0.01).